Overview
Vimta Labs Limited is a comprehensive contract research and testing organization serving industries like pharmaceuticals, food, electronics, and environment testing. With expertise in drug discovery and development, it offers pivotal support for numerous sectors.
The company has experienced a commendable 10.2% year-on-year revenue growth as of Q3 FY26, showcasing resilience and effective market penetration. The diverse testing services offered have significantly contributed to these earnings.
Strategic capacity expansion, especially in biologics and electronics sectors, hints at Vimta Labs Limited's commitment to seize emerging opportunities, reflecting a calculated approach to maximize its operational footprint.
International business continues to bolster Vimta Labs Limited's financial trajectory, with exports contributing around 39% of their income, underscoring its strong global presence, particularly in pharmaceutical analytical services.
- Sector
Healthcare Services
- Industry
Healthcare Research, Analytics & Technology
- Market Cap
2,219 Cr
- Volatility
Moderate Risk
- P/E Ratio
36.2
- Industry P/E
59.9
- PEG Ratio
0.7
- P/B Ratio
6.2
- 52W High
902.85
- 52W Low
377.30
Financial Ratios
Sales CAGR
- 1Y
- 0.02%
- 3Y
- 8.93%
- 5Y
- 14.27%
- 10Y
- 11.42%
Profit CAGR
- 1Y
- -14.86%
- 3Y
- 17.90%
- 5Y
- 29.53%
- 10Y
- 24.75%
ROE
- TTM
- 14.59%
- 3Y
- 16.16%
- 5Y
- 16.48%
- 10Y
- 14.24%
ROCE
- TTM
- 19.04%
- 3Y
- 21.03%
- 5Y
- 21.31%
- 10Y
- 18.76%
Actions
AI Mode
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Ask AI
